AC Camargo Cancer Center
33
11
11
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.1%
3 terminated/withdrawn out of 33 trials
72.7%
-13.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (33)
Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
Role: lead
Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery
Role: lead
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Role: collaborator
Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial
Role: collaborator
Meditation With Virtual Reality for Cancer Pain Relief in the Pain Therapy and Palliative Care Service
Role: collaborator
Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Role: lead
The Effects of Dance for Breast Cancer Patients Undergoing Surgical Treatment
Role: lead
Sentinel Node Mapping in High Risk Endometrial Cancer
Role: lead
Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Role: lead
Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression
Role: lead
Evaluation of Herpes Zoster Characteristics and Costs in Cancer Population.
Role: lead
Focal Intraoperative Radiotherapy of Brain Metastases
Role: lead
Comparison Between Internal Jugular Vein Versus Axillary Vein for Implantable Ports
Role: lead
Effectiveness of Photobiomodulation Protocols in Radiation-induced Oral Side Effects in H&N Cancer Patients
Role: collaborator
Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCT
Role: collaborator
Trastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC
Role: lead
Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy SCC of the Anal Canal (BISQUIT)
Role: lead
Clinical Trial of The Use of Bolus in Post Mastectomy Irradiation in Breast Cancer
Role: lead
Study of MIBG-I131 in Patients With Well Differentiated Neuroendocrine Tumors
Role: lead
Non-inferiority of Clinical Trials in Comparison With the Length of Totally Implemented Porth-a-Cath Maintenance From 60 Versus 90 Days
Role: lead